FDA panel rejects first MDMA treatment amid deep concerns ... - NBC News
WEBJun 4, 2024 · A Food and Drug Administration advisory panel on Tuesday declined to recommend the approval of MDMA, commonly known as ecstasy or molly, as a treatment for post-traumatic stress disorder, a...
FDA advisers reject MDMA as treatment for PTSD : Shots - Health News - NPR
WEBJun 5, 2024 · A panel of experts advising the Food and Drug Administration on the use of the psychedelic MDMA for post-traumatic stress disorder found on Tuesday that the available evidence fails to show...
FDA advisers vote against first MDMA therapy to treat PTSD
WEBJun 4, 2024 · A federal advisory committee on Tuesday voted overwhelmingly against of the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder.
FDA declines to approve novel MDMA therapy to treat PTSD, with ... - CNN
WEBAug 9, 2024 · The US Food and Drug Administration has declined to approve an application for the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, according to a news...
FDA rejects MDMA, disappointing drugmaker Lykos and psychedelics ... - NPR
WEBAug 9, 2024 · On Friday, drugmaker Lykos Therapeutics received word from the Food and Drug Administration that the agency has decided not to approve MDMA-assisted therapy for PTSD at this time. Instead, the...
F.D.A. Declines to Approve MDMA Therapy, Seeking More Study
WEBAug 9, 2024 · The Food and Drug Administration on Friday declined to approve MDMA-assisted therapy for the treatment of post-traumatic stress disorder, dealing a serious blow to the nascent field of...
FDA Panel Rejects Use of MDMA for Treatment of PTSD - The New York Times
WEBJune 4, 2024. An independent advisory panel of the Food and Drug Administration rejected the use of MDMA-assisted therapy for post-traumatic stress disorder on Tuesday, highlighting the...
MDMA Therapy Inches Closer to Approval - The New York Times
WEBSep 14, 2023 · MDMA-assisted therapy seems to be effective in reducing symptoms of post-traumatic stress disorder, according to a study published on Thursday. The research is the final trial conducted by MAPS...
MDMA Drug Developers Reprioritize Following Lykos Rejection in …
WEBSep 30, 2024 · After the FDA declined to approve Lykos Therapeutics’ MDMA-assisted therapy for post-traumatic stress disorder, companies are pivoting away from or delaying similar therapeutics targeting the psychiatric disease.
WATCH: FDA expert panel rejects psychedelic drug MDMA as a …
WEBJun 4, 2024 · WASHINGTON (AP) — A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic...